glp-1 study GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction Mapping the effectiveness and risks
Description
Symptoms range from shakiness and sweating to confusion, seizures, and in severe cases, death
doi: 10.1111/JNC.14694
New conceptions on the functional significance of glucagon (pancreatic and extra-pancreatic) Journees Annuelles de Diabetologie de lHotel-Dieu
The trial randomised adults with obesity who have achieved 5% WL by the end of the 12-week lead-in period (mean WL at the lead-in period was 6.9%) to placebo or tirzepatide
Did You Get Pregnant While Taking GLP-1s
Do not alternate without medical supervision Self-directed medication cycling carries real risks
